Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report by Chen, Yuanbin, MD, PhD, Paz-Ares, Luis, MD, PhD, Reinmuth, Niels, MD, PhD, Garassino, Marina Chiara, MD, Statsenko, Galina, MD, Hochmair, Maximilian J., MD, Özgüroğlu, Mustafa, MD, PhD, Verderame, Francesco, MD, Havel, Libor, MD, Losonczy, György, MD, PhD, Conev, Nikolay V., MD, PhD, Hotta, Katsuyuki, MD, PhD, MPH, Ji, Jun Ho, MD, PhD, Spencer, Stuart, MSc, Dalvi, Tapashi, PhD, MPH, Jiang, Haiyi, MD, Goldman, Jonathan W., MD

Get full text

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer... by Garassino, Marina C, MD, Gadgeel, Shirish, MBBS, Esteban, Emilio, MD, Felip, Enriqueta, PhD, Speranza, Giovanna, MD, Domine, Manuel, PhD, Hochmair, Maximilian J, PhD, Powell, Steven, MD, Cheng, Susanna Yee-Shan, MD, Bischoff, Helge G, MD, Peled, Nir, Prof, Reck, Martin, MD, Hui, Rina, PhD, Garon, Edward B, MD, Boyer, Michael, MD, Wei, Ziwen, PhD, Burke, Thomas, PhD, Pietanza, M Catherine, MD, Rodríguez-Abreu, Delvys, MD

Get full text

Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial by Wolf, Jürgen, MD, Hochmair, Maximilian, MD, Han, Ji-Youn, MD PhD, Reguart, Noemi, MD PhD, Souquet, Pierre-Jean, MD, Smit, Egbert F, MD PhD, Orlov, Sergey V, MD PhD, Vansteenkiste, Johan, MD PhD, Nishio, Makoto, MD PhD, de Jonge, Maja, MD PhD, Akerley, Wallace, MD, Garon, Edward B, MD, Groen, Harry J M, MD PhD, Tan, Daniel S W, MD PhD, Seto, Takashi, MD, Frampton, Garrett M, PhD, Robeva, Anna, MS, Carbini, Mariana, MD, Le Mouhaer, Sylvie, MSc, Yovine, Alejandro, MD, Boran, Aislyn, PhD, Bossen, Claudia, PhD, Yang, Yiqun, PhD, Ji, Lexiang, PhD, Fairchild, Lauren, PhD, Heist, Rebecca S, MD

Get full text

Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials by Gettinger, Scott N., MD, Huber, Rudolf M., MD, Kim, Dong-Wan, XX, Bazhenova, Lyudmila, XX, Hansen, Karin Holmskov, XX, Tiseo, Marcello, XX, Langer, Corey J., XX, Paz-Ares Rodríguez, Luis G., XX, West, Howard L., XX, Reckamp, Karen L., XX, Weiss, Glen J., XX, Smit, Egbert F., XX, Hochmair, Maximilian J., XX, Kim, Sang-We, XX, Ahn, Myung-Ju, XX, Kim, Edward S., XX, Groen, Harry J.M., XX, Pye, Joanna, XX, Liu, Yuyin, XX, Zhang, Pingkuan, XX, Vranceanu, Florin, XX, Camidge, D. Ross, XX

Get full text